Balance Sheet Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 10:26:15 2024-09-19 am EDT			5-day change	1st Jan Change
29.82 ^USD	+0.24%		+2.56%	+3.88%

Sep. 18	GSK settles two California lawsuits related to heartburn drug Zantac	RE
Sep. 18	Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports	RE

b3e19a041d22.6wU-IRKQCxO5DhhDk0MhhaMXaSxXi0d0jM9cRBMIvfk.sTJIQ2HgbVbNdGwk4TYS1_J2GGNuuQFC3JwvLSdf0M-ydGlkdfhjX8NMVQ

Published financial data: PFIZER, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	51.75B	41.91B	81.29B	100B	58.5B
Total Revenues	51.75B	41.91B	81.29B	100B	58.5B
Cost of Goods Sold, Total	10.01B	8.57B	30.66B	34.1B	23.99B
Gross Profit	41.74B	33.33B	50.63B	66.23B	34.51B
Selling General & Admin Expenses, Total	14.1B	10.89B	9.56B	12.2B	13.84B
R&D Expenses	7.98B	8.88B	10.52B	11.43B	10.68B
Amortization of Goodwill and Intangible Assets - (IS)	4.61B	3.44B	3.7B	3.61B	4.73B
Other Operating Expenses, Total	26.7B	23.2B	23.78B	27.24B	29.25B
Operating Income	15.04B	10.13B	26.84B	39B	5.26B
Interest Expense, Total	-1.57B	-1.45B	-1.29B	-1.24B	-2.21B
Interest And Investment Income	446M	351M	202M	565M	2.1B
Net Interest Expenses	-1.13B	-1.1B	-1.09B	-673M	-109M
Income (Loss) On Equity Invest.	17M	298M	471M	436M	505M
Currency Exchange Gains (Loss)	-172M	-	-192M	-1.15B	164M
Other Non Operating Income (Expenses)	1.31B	2.29B	1.88B	2.62B	1.28B
EBT, Excl. Unusual Items	15.07B	11.62B	27.92B	40.22B	7.09B
Restructuring Charges	-1.28B	-859M	-1.36B	-2.02B	-3.33B
Merger & Related Restructuring Charges	-2M	-528M	-	-200M	-668M
Gain (Loss) On Sale Of Investments	8.54B	546M	1.34B	-1.27B	1.59B
Gain (Loss) On Sale Of Assets	31M	-237M	99M	-	222M
Asset Writedown	-2.84B	-1.69B	-86M	-421M	-3.02B
In Process R&D Expenses	-	-	-	-953M	-194M
Insurance Settlements	50M	-	-	-	-
Legal Settlements	-472M	-28M	-182M	-230M	-474M
Other Unusual Items	-1.42B	-1.32B	-3.42B	-394M	-157M
EBT, Incl. Unusual Items	17.68B	7.5B	24.31B	34.73B	1.06B
Income Tax Expense	1.38B	477M	1.85B	3.33B	-1.12B
Earnings From Continuing Operations	16.3B	7.02B	22.46B	31.4B	2.17B
Earnings Of Discontinued Operations	4M	2.63B	-434M	6M	-15M
Net Income to Company	16.3B	9.65B	22.02B	31.41B	2.16B
Minority Interest	-29M	-36M	-45M	-35M	-39M
Net Income - (IS)	16.27B	9.62B	21.98B	31.37B	2.12B
Preferred Dividend and Other Adjustments	1M	-	-	-	-
Net Income to Common Incl Extra Items	16.27B	9.62B	21.98B	31.37B	2.12B
Net Income to Common Excl. Extra Items	16.27B	6.98B	22.41B	31.37B	2.13B
Per Share Items
Net EPS - Basic	2.92	1.73	3.92	5.59	0.38
Basic EPS - Continuing Operations	2.92	1.26	4	5.59	0.38
Basic Weighted Average Shares Outstanding	5.57B	5.56B	5.6B	5.61B	5.64B
Net EPS - Diluted	2.87	1.71	3.85	5.47	0.37
Diluted EPS - Continuing Operations	2.87	1.24	3.93	5.47	0.37
Diluted Weighted Average Shares Outstanding	5.68B	5.63B	5.71B	5.73B	5.71B
Normalized Basic EPS	1.69	1.3	3.11	4.48	0.78
Normalized Diluted EPS	1.65	1.28	3.05	4.38	0.77
Dividend Per Share	1.44	1.52	1.56	1.6	1.64
Payout Ratio	49.43	87.77	39.72	28.63	436.38
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	21.01B	14.89B	31.95B	44.02B	11.52B
EBITA	19.65B	13.56B	30.54B	42.6B	9.99B
EBIT	15.04B	10.13B	26.84B	39B	5.26B
EBITDAR	21.71B	15.66B	32.84B	45.24B	12.8B
Total Revenues (As Reported)	-	-	-	-	58.5B
Effective Tax Rate - (Ratio)	7.83	6.36	7.62	9.58	-105.39
Current Domestic Taxes	-1.94B	429M	3.38B	2.72B	1.19B
Current Foreign Taxes	2.9B	1.52B	2.77B	4.37B	1.14B
Total Current Taxes	958M	1.95B	6.14B	7.09B	2.33B
Deferred Domestic Taxes	1.35B	-1.18B	-4.34B	-3.58B	-2.79B
Deferred Foreign Taxes	-919M	-292M	48M	-183M	-652M
Total Deferred Taxes	427M	-1.47B	-4.29B	-3.76B	-3.44B
Normalized Net Income	9.39B	7.23B	17.4B	25.11B	4.39B
Interest Capitalized	88M	96M	108M	124M	160M
Non-Cash Pension Expense	206M	-76M	-2.14B	-247M	-508M
Supplemental Operating Expense Items
Advertising Expense	2.6B	1.8B	2B	2.8B	3.7B
Selling and Marketing Expenses	2.6B	1.8B	2B	2.8B	3.7B
Research And Development Expense From Footnotes	8.65B	9.4B	13.83B	11.43B	10.68B
Net Rental Expense, Total	700M	773M	888M	1.22B	1.28B
Imputed Operating Lease Interest Expense	195M	202M	240M	329M	424M
Imputed Operating Lease Depreciation	505M	571M	648M	889M	859M
Stock-Based Comp., Other (Total)	738M	776M	1.2B	891M	545M
Total Stock-Based Compensation	738M	776M	1.2B	891M	545M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	1.3B	1.78B	1.94B	416M	2.85B
Short Term Investments	8.52B	10.44B	29.12B	22.32B	9.84B
Trading Asset Securities, Total	53M	18M	4M	-	-
Total Cash And Short Term Investments	9.88B	12.24B	31.07B	22.73B	12.69B
Accounts Receivable, Total	8.72B	7.93B	11.48B	10.95B	11.18B
Other Receivables	3.34B	3.26B	4.27B	3.58B	3.98B
Total Receivables	12.07B	11.19B	15.74B	14.53B	15.16B
Inventory	8.28B	8.05B	9.06B	8.98B	10.19B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	2.57B	3.59B	3.82B	5.02B	5.3B
Total Current Assets	32.8B	35.07B	59.69B	51.26B	43.33B
Gross Property Plant And Equipment	32.07B	30.1B	32.8B	34.45B	37.91B
Accumulated Depreciation	-16.79B	-14.81B	-15.07B	-15.17B	-16.04B
Net Property Plant And Equipment	15.28B	15.29B	17.72B	19.28B	21.86B
Long-term Investments	20.41B	20.38B	21.54B	14.93B	15.38B
Goodwill	58.65B	49.58B	49.21B	51.38B	67.78B
Other Intangibles, Total	35.37B	28.47B	25.15B	43.37B	64.9B
Deferred Tax Assets Long-Term	900M	900M	1.6B	4.8B	1.8B
Other Long-Term Assets, Total	4.07B	4.54B	6.57B	12.2B	11.44B
Total Assets	167B	154B	181B	197B	227B
Liabilities
Accounts Payable, Total	4.22B	4.31B	5.58B	6.81B	6.71B
Accrued Expenses, Total	6.59B	6.51B	7.67B	8.32B	9.22B
Short-term Borrowings	14.73B	701M	605M	385M	8.1B
Current Portion of Long-Term Debt	1.46B	2B	1.64B	2.57B	2.27B
Current Portion of Leases	276M	321M	449M	620M	527M
Current Income Taxes Payable	980M	1.05B	1.27B	1.59B	2.35B
Unearned Revenue Current, Total	9M	957M	4.02B	2.52B	2.7B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	9.04B	10.07B	21.44B	19.33B	15.92B
Total Current Liabilities	37.3B	25.92B	42.67B	42.14B	47.79B
Long-Term Debt	35.96B	37.13B	36.2B	33.2B	61.81B
Long-Term Leases	1.05B	1.11B	2.51B	2.6B	2.63B
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	6.76B	5.41B	3.72B	2.25B	2.17B
Deferred Tax Liability Non Current	5.58B	4.06B	349M	1.02B	640M
Other Non Current Liabilities	17.4B	17.12B	18.56B	20.08B	22.17B
Total Liabilities	104B	90.76B	104B	101B	137B
Preferred Stock Convertible	17M	-	-	-	-
Total Preferred Equity	17M	-	-	-	-
Common Stock, Total	468M	470M	473M	476M	478M
Additional Paid In Capital	87.43B	88.67B	90.59B	91.8B	92.63B
Retained Earnings	97.67B	96.77B	103B	126B	118B
Treasury Stock	-111B	-111B	-111B	-114B	-114B
Comprehensive Income and Other	-11.64B	-11.69B	-5.9B	-8.3B	-7.96B
Total Common Equity	63.13B	63.24B	77.2B	95.66B	89.01B
Minority Interest	303M	235M	262M	256M	274M
Total Equity	63.45B	63.47B	77.46B	95.92B	89.29B
Total Liabilities And Equity	167B	154B	181B	197B	227B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.55B	5.58B	5.62B	5.62B	5.65B
ECS Total Common Shares Outstanding	5.53B	5.57B	5.62B	5.62B	5.65B
Book Value / Share	11.41	11.36	13.74	17.03	15.77
Tangible Book Value	-30.9B	-14.81B	2.85B	916M	-43.67B
Tangible Book Value Per Share	-5.58	-2.66	0.51	0.16	-7.73
Total Debt	53.47B	41.27B	41.4B	39.38B	75.33B
Net Debt	43.59B	29.03B	10.32B	16.64B	62.64B
Debt Equivalent of Unfunded Proj. Benefit Obligation	5.4B	4.4B	1.73B	1.18B	561M
Debt Equivalent Oper. Leases	5.6B	6.18B	7.1B	9.74B	10.26B
Minority Interest, Total (Incl. Fin. Div)	303M	235M	262M	256M	274M
Equity Method Investments, Total	17.13B	16.86B	16.47B	11.03B	11.64B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	790M	738M	994M	859M	1.01B
Inventories - Work In Process, Total	4.74B	4.43B	4.42B	5.52B	5.69B
Inventories - Finished Goods, Total	2.75B	2.88B	3.64B	2.6B	3.5B
Land - (BS)	516M	444M	423M	368M	353M
Buildings, Total	10.07B	9.02B	9B	8.83B	9.05B
Machinery, Total	17.21B	15.69B	16.71B	17.37B	19.66B
Full Time Employees	88.3K	78.5K	79K	83K	88K
Accumulated Allowance for Doubtful Accounts (Supple)	527M	508M	492M	449M	470M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	16.27B	9.62B	21.98B	31.37B	2.12B
Depreciation & Amortization - CF	1.36B	1.32B	1.4B	1.42B	1.52B
Amortization of Goodwill and Intangible Assets - (CF)	4.61B	3.44B	3.7B	3.61B	4.73B
Depreciation & Amortization, Total	5.97B	4.76B	5.1B	5.03B	6.26B
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-8.23B	-6M	-	-	-
Asset Writedown & Restructuring Costs	2.99B	2.07B	363M	586M	3.44B
Stock-Based Compensation (CF)	718M	756M	1.18B	872M	525M
Net Cash From Discontinued Operations	-	3.82B	-343M	-	15M
Other Operating Activities, Total	-1.1B	-6.33B	-8.51B	-4.14B	-1.48B
Change In Accounts Receivable	-742M	-1.25B	-3.81B	261M	347M
Change In Inventories	-1.05B	-736M	-1.12B	592M	-1.17B
Change In Accounts Payable	-564M	353M	1.24B	1.19B	-300M
Change in Other Net Operating Assets	-1.68B	1.36B	16.5B	-6.5B	-1.05B
Cash from Operations	12.59B	14.4B	32.58B	29.27B	8.7B
Capital Expenditure	-2.18B	-2.25B	-2.71B	-3.24B	-3.91B
Cash Acquisitions	-10.86B	-	-	-23B	-43.43B
Sale (Purchase) of Intangible assets	-418M	-539M	-	-	-
Investment in Marketable and Equity Securities, Total	9.3B	-1.67B	-19.52B	6.68B	15.24B
Other Investing Activities, Total	206M	192M	-318M	3.77B	-180M
Cash from Investing	-3.94B	-4.27B	-22.55B	-15.78B	-32.28B
Short Term Debt Issued, Total	19.01B	12.35B	-	3.89B	7.69B
Long-Term Debt Issued, Total	4.94B	5.22B	997M	-	30.83B
Total Debt Issued	23.95B	17.57B	997M	3.89B	38.52B
Short Term Debt Repaid, Total	-8.38B	-26.33B	-96M	-4.11B	-3M
Long-Term Debt Repaid, Total	-6.81B	-4B	-2B	-3.3B	-2.57B
Total Debt Repaid	-15.18B	-30.33B	-2.1B	-7.41B	-2.57B
Issuance of Common Stock	394M	425M	-	-	-
Repurchase of Common Stock	-8.86B	-	-	-2B	-
Common Dividends Paid	-	-8.44B	-8.73B	-8.98B	-9.25B
Common & Preferred Stock Dividends Paid	-8.04B	-	-	-	-
Common & Preferred Stock Dividends Paid	-8.04B	-8.44B	-8.73B	-8.98B	-9.25B
Other Financing Activities, Total	-735M	11.12B	16M	-335M	-632M
Cash from Financing	-8.48B	-9.65B	-9.82B	-14.83B	26.07B
Foreign Exchange Rate Adjustments	-32M	-8M	-59M	-165M	-40M
Miscellaneous Cash Flow Adjustments	-1M	-	-	-	-
Net Change in Cash	125M	475M	159M	-1.52B	2.45B
Supplemental Items
Cash Interest Paid	1.59B	1.64B	1.47B	1.44B	2.22B
Cash Income Tax Paid (Refund)	3.66B	3.15B	7.43B	7.87B	3.15B
Levered Free Cash Flow	18.42B	10.5B	30.86B	24.96B	1.02B
Unlevered Free Cash Flow	19.4B	11.41B	31.66B	25.73B	2.4B
Change In Net Working Capital	-5.89B	-2.33B	-11.29B	1.32B	3.78B
Net Debt Issued / Repaid	8.76B	-12.76B	-1.1B	-3.52B	35.94B